News US checks out of WHO, leaving its bill unsettled A year after President Trump signed an order for the US to withdraw from the WHO, the exit is taking place today, with $260m in fees left unpaid.
News WHO sounds alarm over rising tide of antibiotic resistance One in six common bacterial infections in people worldwide in 2023 were resistant to antibiotic treatments, according to the WHO.
News Gilead's twice-yearly HIV PrEP set for wider rollout The WHO has recommended Gilead's twice-yearly HIV PrEP drug lenacapavir, calling it 'transformational', but there are concerns about patient access.
News Experts deplore Trump's order for US to exit from WHO One of the first acts of President Donald Trump after his inauguration yesterday was to order the start of the US's withdrawal from the WHO.
R&D Growing threat of AMR: UN calls for urgent global action In response to the rise of AMR, world leaders recently convened at the United Nations General Assembly to forge a landmark commitment, setting ambitious targets and funding initiatives to c
R&D Mpox is on the rise again as outbreak gathers pace The original mpox outbreak began in 2022, but case numbers have rumbled on, despite countermeasures.
News United's PAH drug clears phase 3 trial, setting up filings United Therapeutics will file ralinepag as a treatment for pulmonary arterial hypertension later this year, but can it compete in a crowded market?
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.